Shiseido claims to have found a cure for baldness, available from 2018
July 9, 2015 Written by Zoe Efstathiou
Source: globalcosmeticsnews.com
Japan-based hair and cosmetics company
Shiseido claims to have found a cure for baldness which it plans to make
commercially available by 2018.
The company has patented its new RepliCel
Hair-01 (RCH-01) hair regeneration technology in the entire Asian region,
including Japan, which comprises approximately 2.1 billion people.
RCH-01 has been developed over 10 years
of scientific research, and safe application in humans has been now been
validated through clinical
trials.
The treatment uses “autologous cell
transplantation technology,” in
which specific cells isolated
from the hair
follicles taken from the scalp of a patient are cultured and
implanted (injected) into the balding
scalp area, potentially
stimulating residing hair follicles and promoting new hair growth.
The treatment has been created by
scientists at The Kobe Biomedical Innovation Cluster, a biomedical research center
located in Port Island, which is one of the core bases of the Kansai Innovation
International Strategic
Comprehensive Special Zone
designated by the
Japanese government to
promote industrial development in
advanced medicine and to provide a competitive advantage in the international
market.
The Cluster is the largest
national cluster zone
specialized in life
sciences, with the
focus on promoting
translation of leading scientific
research and advanced knowledge in regenerative medicine into clinical use.
There are
over 270 biomedical companies,
academic, medical, and
government organizations situated
at the center working on the clinical application of regenerative medicine and the development of
new pharmaceutical products and medical equipment.
